EDE Medical Device Dossier Checklist: Verification Order for Official Service-Page Documents

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The EDE dossier checklist is not a table of contents. It is an evidence system built on the framework of Article 6(1)(a–h) of Federal Decree-Law No. 38 of 2024. The service page states a review timeline of 45 working days, an application fee of AED 100, a medical device registration fee of AED 5,000, and a certificate valid for 5 years from the date of committee approval; however, a single deficiency request can stretch the calendar timeline by several months. Our recommendation is that the verification order should be re-sorted by rejection risk: eligibility and establishment documents first, then the certification chain, then the quality system certificates, and only afterwards the product technical evidence and label samples. Compressing the lead time on eligibility-type documents is the single most effective action for lowering the probability of a deficiency request.

  • The official checklist is an evidence system anchored in Article 6(1)(a–h), not a simple list of documents.
  • Official timelines: 45 working days for review, AED 100 application fee, AED 5,000 registration fee, 5-year certificate validity.
  • One deficiency request can add months to the calendar timeline even when the official review clock is short.
  • Verification order should follow rejection risk, not the order in which the service page lists items.
  • Eligibility documents carry the highest rejection risk and therefore deserve the earliest verification effort.

2. Legal basis

The regulatory basis for the dossier combines the EDE service page for marketing authorization with the substantive conditions of Federal Decree-Law No. 38 of 2024. The table below reproduces the instruments cited in the source material and their key points.

EDE service page: Issuance of Marketing Authorization for a Medical DeviceIssuance of Marketing Authorization for a Medical Device (service page, no instrument number)Currently published on the EDE websiteList of required documentsApplication form, valid factory registration certificate, free sale or registration certificate issued by the competent authority of the country of origin and attested by the UAE embassy, product agency contract, quality conformity or marketing authorization documents submitted by classification (EC, 510(k), PMA), post-market surveillance requirements, product information and packaging artwork, laboratory requirements and pricing for specific devices, samples and certificates of analysis, EC declaration of conformity, safety and effectiveness data for Class III/IV devices, conformity certificate for products of animal origin
UAE Federal Decree-Law on the Regulation of Medical Products, Pharmacists and Pharmaceutical EstablishmentsFederal Decree-Law No. 38 of 2024Published in the Official Gazette on 2024-10-14; entered into force on 2025-01-02Article 6(1)(a–h)(a) the applicant must be a marketing office, manufacturer, contract manufacturing company, or medical warehouse designated by the rights holder; (f) GMP certificate; (g) complete information on inner and outer packaging and the package insert, compliant with the EDE labelling guidance; (h) other conditions set out in the Executive Regulations
UAE Federal Decree-Law on the Regulation of Medical Products, Pharmacists and Pharmaceutical EstablishmentsFederal Decree-Law No. 38 of 2024Published in the Official Gazette on 2024-10-14; entered into force on 2025-01-02Article 7The marketing authorization is valid for 5 years and may be renewed in accordance with the rules

3. Expert insights

Insight 1: The document chain precedes technical content. We divide the official checklist into two clusters: eligibility documents and technical documents. For the eligibility cluster — the factory registration certificate, the MAH registration status, the agency contract, and the free sale certificate attested by the UAE embassy — a single missing item means the application is returned at the acceptance stage, no matter how complete the technical file may be. This is the core basis for re-sorting the verification order: the documents with the highest risk go first, rather than preparing each item in the sequence listed on the service page.

Insight 2: The real meaning of submission by classification is that evidence strength must match the risk class. The service page requires quality conformity or marketing authorization documents such as EC certificates, 510(k) clearances, and PMA approvals to be submitted according to the classification. Our judgment is that EDE examines whether the strength of the evidence is commensurate with the risk class of the product, not whether some certificate exists. Supporting a high-risk device submission with a Class I self-declaration is an evidence hierarchy shortfall; for Class III/IV devices, safety and effectiveness data must additionally be submitted, and this is the item most frequently underestimated by Chinese manufacturers in a first submission.

Insight 3: The EC declaration of conformity and the quality conformity documents are two separate pieces of evidence. The checklist lists both, which shows that EDE does not accept a declaration of conformity as a substitute for the system and product evidence. Our arrangement is to place the declaration of conformity at the front of the dossier as an index page, followed in sequence by the CE certificate, the ISO 13485 certificate, and the technical documentation summary, so that the reviewer can navigate the dossier directly and the cross-checking that generates deficiency requests is reduced.

4. Practical recommendations

  • Complete the EDE registration of the factory and the MAH before starting the product submission; the service page states explicitly that the MAH and the manufacturing site must first be registered with EDE, and that the marketing office or medical warehouse must hold a valid licence.
  • Re-sort the verification order by rejection risk: eligibility documents, then the certification chain, then system certificates, then product evidence, then labels and samples, then pricing and laboratory requirements.
  • Build a cross-reference table for every document, recording the issuing body, the attestation status, the validity period, and the corresponding subparagraph of Article 6, and tick each cell before submission.
  • For Class III/IV devices, prepare the safety and effectiveness data package in advance and structure it in line with the reference country approval documents, so that it can be compared easily during reliance review.
  • Before submission, lock in the classification through the EDE classification service, for which the official timeline is 10 working days, and avoid reworking the entire evidence package prepared under a wrong classification.
  • Pricing and laboratory requirements are standalone items within the checklist and should be prepared in parallel with the registration dossier; do not wait until the marketing authorization has been obtained to address them.

5. Verification checklist

  • □ The factory has completed registration with EDE and the registration certificate is within its validity period
  • □ The MAH (marketing office or medical warehouse) has completed registration and holds a valid licence
  • □ The free sale or registration certificate has been issued by the competent authority of the country of origin and attested by the UAE embassy
  • □ The parties to the product agency contract match the applicant and the MAH exactly by legal name
  • □ The ISO 13485 and GMP certificates cover the products to be registered and are not close to expiry
  • □ Quality conformity documents at the appropriate evidence level (EC, 510(k), PMA or equivalent) have been submitted according to the classification
  • □ The EC declaration of conformity, the product information, and the inner and outer packaging artwork are mutually consistent
  • □ The post-market surveillance statement, the samples, and the certificates of analysis are ready as required by the service page

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the United Arab Emirates. Our team prepares MOHAP-compliant dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail